Celebrating 10 years of innovative, global,
Regulatory solutions & services for Life Sciences industry

How Marketing Authorisation Applications Referred Under Article 29 will be Handled from 1 January 2021

From 1 January 2021, Northern Ireland will continue to participate in referrals under Article 29. For applications where the MHRA had a positive opinion at Day 210 of a DCP or Day 90 of an MRP, a Marketing Authorisation will be granted following receipt of the national product information. No additional or different fee will be charged for applications that are completed as a national procedure having previously been referred under Article 29.

Source: MHRA guideline on How Marketing Authorisation Applications referred under Article 29 will be handled from 1 January 2021

Latest Resources

  • Blogs

    Brexit: The MHRA and The Proposed eSubmission Portal

    Read More
  • White Papers

    Impact of COIVD – 19 on FMCG Supply Chain Regulatory Compliance

    Read More
  • Case Studies

    Expedited Product Classification and NIOSH Certification for N95 Respirator

    Read More

What our Clients Say?

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Quick Inquiry
x